Subcellular fate and off-target effects of siRNA, shRNA, and miRNA

Saurabh Singh, Ajit S. Narang, Ram I. Mahato

Research output: Contribution to journalReview article

110 Scopus citations

Abstract

RNA interference (RNAi) strategies include double-stranded RNA (dsRNA), small interfering RNA (siRNA), short hairpin RNA (shRNA), and microRNA (miRNA). As this is a highly specific technique, efforts have been made to utilize RNAi towards potential knock down of disease-causing genes in a targeted fashion. RNAi has the potential to selectively inhibit gene expression by degrading or blocking the translation of the target mRNA. However, delivering these RNAs to specific cells presents a significant challenge. Some of these challenges result from the necessity of traversing the circulatory system while avoiding kidney filtration, degradation by endonucleases, aggregation with serum proteins, and uptake by phagocytes. Further, non-specific delivery may result in side-effects, including the activation of immune response. We discuss the challenges in the systemic delivery to target cells, cellular uptake, endosomal release and intracellular transport of RNAi drugs and recent progress in overcoming these barriers. We also discuss approaches that increase the specificity and metabolic stability and reduce the off-target effects of RNAi strategy.

Original languageEnglish (US)
Pages (from-to)2996-3015
Number of pages20
JournalPharmaceutical Research
Volume28
Issue number12
DOIs
Publication statusPublished - Dec 1 2011

    Fingerprint

Keywords

  • RNA interference
  • cellular uptake
  • intracellular trafficking
  • miRNA
  • shRNA
  • siRNA

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

Cite this